Ailles Lab

Ailles Lab Dr. Ailles and her team are focusing on two major research areas, intra-tumoural heterogeneity and epigenetics in clear cell renal cell carcinoma (ccRCC).

Al-Awar Lab

Al-Awar Lab The goal of the Drug Discovery group is to optimize lead molecules and progress them to drug candidates that can translate into therapeutic benefits to cancer patients.

Aldape Lab

Aldape Lab Dr. Aldape is a neuropathologist and laboratory scientist with research interests in brain tumours and cancer genomics in general.

Awadalla Lab

Awadalla Lab Dr. Awadalla and his team focuses on next-generation genomics approaches, model-based tools and population-based approaches to study cancer.

Bartlett Lab

Bartlett Lab Dr. Bartlett is developing new diagnostic approaches to improve patient diagnosis and treatment.

Bedard Lab

Bedard Lab Dr. Bedard is Co-Principal Investigator of the Ontario-wide Cancer Targeted Nucleic Acid Evaluation (OCTANE) study.

Bell Lab

Bell Lab Dr. Bell’s lab has shown that a variety of viruses selectively replicate in and kill cancer cell lines while leaving healthy parts of the body intact.

Boutros Lab

Boutros Lab Dr. Boutros' team uses biological big data to create new biomarkers that personalize therapy for individual patients.

Butler Lab

Butler Lab Dr. Butler is Co-leader of OICR's Immuno-oncology Translational Research Initiative (ACTION).

Dancey Lab

Dancey Lab Dr. Janet Dancey is the leader of the Canadian Cancer Clinical Trials Network (3CTN) and the Canadian Cancer Trials Group (CCTG)

Dick Lab

Dick Lab Dr. Dick’s world-renowned research program centers on the theme that genetic and non-genetic determinants of tumour heterogeneity are linked through stemness.

Dirks Lab

Dirks Lab Dr. Dirks is Co-leader of OICR's Brain Cancer Translational Research Initiative.

Feilotter Lab

Feilotter Lab Dr. Feilotter focuses on the development of biomarkers to be used in the screening, diagnosis or treatment of human diseases, including cancer.

Fenster Lab

Fenster Lab Dr. Fenster is driven by the opportunity to use technological innovations to meet the challenges of cancer diagnosis and therapy needs.

Ferretti Lab

Ferretti Lab Dr. Ferretti’s expertise is in bioinformatics with experience in both large-scale software development and computational genomics.

Fong Lab

Fong Lab Dr. Fong is the founder of the International Tobacco Control Policy Evaluation Project. This project's objective is to evaluate the impact of policies designed to control tobacco use.

Gallinger Lab

Gallinger Lab Dr. Gallinger is Leader of OICR's Pancreatic Cancer Translational Research Initiative (PanCuRx).

Genome Sequence Informatics

Genome Sequence Informatics GSI assists collaborators in experimental design, as well as the interpretation of the results and the publication of experimental results.

Genome Technologies Platform

Genome Technologies Platform Supporting researchers in many applications: FFPE & low-input samples, high volume studies, targeted panels, long read sequencing, single cell sequencing, low variant detection, and much more

Grunfeld Lab

Grunfeld Lab The focus of Dr. Grunfeld’s research is the evaluation of access to and quality of cancer care across the cancer control continuum – from screening to end-of-life care.

Haider Lab

Haider Lab Dr. Haider’s research focus is abdominal and pelvic MRI with an interest in therapeutic response assessment and quantitative imaging of cancer.

Hanna Lab

Hanna Lab Dr. Hanna’s research focuses on three translational streams of health services research: quality of care, value of care and access to care.

Hirano Lab

Hirano Lab The overarching goal of Dr. Hirano’s research is to devise novel anti-tumour immunotherapeutic modalities that can cure cancer.

Hope Lab

Hope Lab Dr. Hope aims to identify the underlying processes that lead to the transformation of healthy cells into leukemic cells and contribute to the progression of the disease.

Jamaspishvili Lab

Jamaspishvili Lab Dr. Jamaspishvili’s research interest and project goals are to identify and validate promising diagnostic and prognostic biomarkers for early prostate cancer.

Juergens Lab

Juergens Lab Dr. Juergens is an OICR Clinician-Scientist.

Kornaga Lab

Kornaga Lab Dr. Kornaga is an OICR associate researcher.

LeBrun Lab

LeBrun Lab Dr. LeBrun’s research group studies perturbations in the regulation of gene transcription that underlie acute lymphoblastic leukemia.

Lerner-Ellis Lab

Lerner-Ellis Lab Dr. Lerner-Ellis's laboratory provides clinical diagnostic services for hereditary breast, ovarian and colon cancer and other genetic testing areas.

Lupien Lab

Lupien Lab Dr. Lupien’s research highlights the need to characterize and understand the role of noncoding regulatory elements as targets of genetic and epigenetic changes in oncogenesis.

McPherson Lab

McPherson Lab Dr. McPherson is an OICR associate researcher specializing in genome technologies.

Moore Lab

Moore Lab Dr. Moore's major research interest is in new drug development for pancreatic cancer.

Nieman Lab

Nieman Lab Dr. Nieman is studying the developmental impact of chemotherapy agents with a goal of improved brain development and quality of life in childhood cancer patients.

Notta Lab

Notta Lab Dr. Notta is an OICR associate researcher.

Oza Lab

Oza Lab Dr. Oza is Co-leader of OICR's Ovarian Cancer Translational Research Initiative.

Palma Lab

Palma Lab Dr. Palma's research focuses on new imaging technologies used with radiotherapy to improve tumour targeting and to deliver higher doses of radiotherapy than previously possible.

Pearson Lab

Pearson Lab Dr. Pearson’s lab is trying to understand the connection between adult stem cells and cancer by using the freshwater planarian as an in vivo model system.

Pond Lab

Pond Lab Dr. Pond’s research interest is in statistical methodologies and analysis of cancer clinical trials, with an aim to facilitate the translation of scientific discoveries into the clinic.

Pugh Lab

Pugh Lab Dr. Pugh is Co-Director of the Princess Margaret-OICR Translational Genomics Laboratory and an OICR associate researcher.

Rauh Lab

Rauh Lab Dr. Rauh’s research vision is to enact a paradigm shift from reactive bone marrow tests to proactive peripheral blood surveillance for myeloid cancers.

Reimand Lab

Reimand Lab The Reimand Lab develops and applies methods to interpret cancer data using pathway and network information.

Rottapel Lab

Rottapel Lab The Rottapel laboratory uses functional genetic screens (both shRNA and CRISPR/Cas9) to identify novel vulnerabilities in ovarian cancer as a strategy to develop new therapeutic targets.

Schimmer Lab

Schimmer Lab Dr. Schimmer is Co-leader of OICR's Acute Leukemia Translational Research Initiative.

Scholl Lab

Scholl Lab Dr. Scholl is focusing on developing an emergent technique for molecular imaging with magnetic resonance

Sidhu Lab

Sidhu Lab The Sidhu lab uses combinatorial libraries to develop synthetic peptides, proteins and antibodies that can be used to track and modulate signalling proteins.

Simpson Lab

Simpson Lab The Simpson lab develops algorithms and software for the analysis of high-throughput sequencing data.

Siu Lab

Siu Lab Dr. Siu is Co-Principal Investigator of the Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (OCTANE) study.

Stein Lab

Stein Lab Dr. Stein is Head of Adaptive Oncology at OICR. His research focuses on using network and pathway-based analysis to identify common mechanisms in multiple cancer types and to devise prognostic and predictive signatures.

Taylor Lab

Taylor Lab Dr. Taylor is Co-leader of OICR's Brain Cancer Translational Research Initiative.

Translational Genomics Laboratory

Translational Genomics Laboratory TGL enhances rapid access to genomics technologies, and facilitates genomic interpretation and reporting in clinical oncology.

Web Development

Web Development The OICR webdev team designs and builds websites and web applications that enable OICR to present leading-edge cancer research that engages a global community for collaboration.

Wouters Lab

Wouters Lab Dr. Wouters’ lab has identified new signaling pathways that influence how tumours respond to environments with reduced oxygenation.

Yaffe Lab

Yaffe Lab Dr. Yaffe’s research is directed toward development and improvement of imaging techniques for the earlier detection, diagnosis and treatment of cancer

Yeung Lab

Yeung Lab Dr. Yeung's research program aims to target chemoresistance in ovarian cancer.

Request an OICR Lab Space

The OICR Labs website empowers OICR researchers and their teams to communicate their goals and share research assets related to their labs. OICR Labs enables full-access GitHub repositories to members to produce any type of webpage, and enables semantic-level search capabilities between lab websites. If you would like your own OICR lab website to be listed above:

SUBMIT A REQUEST FOR YOUR LAB